Erythropoietin: Is it more than correcting anaemia?

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 20-22

  Bahlmann, Ferdinand H ^a   de Groot, Kirsten ^a   Haller, Hermann ^a   Fliser, Danilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Anaemia; Cardiovascular regeneration; Endothelial progenitor cells; Erythropoietin; Pleiotropic effects

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; DRUG MECHANISM; EDITORIAL; ENDOTHELIUM CELL; ERYTHROCYTE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY FAILURE; MITOGENESIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RISK FACTOR; STEM CELL; SUBSTITUTION THERAPY; TISSUE OXYGENATION; VASCULAR ENDOTHELIUM;

ANEMIA; EMBRYO; ENDOTHELIAL CELLS; ERYTHROCYTES; ERYTHROPOIETIN; GROWTH SUBSTANCES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0347917081     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg455     Document Type: Editorial

References (30)

1. Carnot P, Deflandre C. Sur l'activite hemopoietique du serum an cours de la regeneration du sang. [Haemopoietic activity of the serum in blood regeneration.] C R Acad Sci (Paris) 1906; 143: 384-386
2. Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252: 5558-5564
3. Lin FK, Suggs S, Lin CH et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82: 7580-7584
4. Jacobs K, Shoemaker C, Rudersdorf R et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985; 313: 806-810
5. Jacobs C, Horl WH, Macdougall IC et al. European best practice guidelines 9-13: anaemia management. Nephrol Dial Transplant 2000; 15 [Suppl 4]: 33-42
6. Demetri GD, Kris M, Wade J et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 1998; 16: 3412-3425
7. Lappin TR, Maxwell P, Johnston PG. Epo's alter ego: erythropoietin has multiple actions. Stem Cells 2002; 20: 485-492
8. Sasaki R, Masuda S, Nagao M. Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol Sci 2001; 16: 110-113
9. Goldman SA, Nedergaard M. Erythropoietin strikes a new cord. Nat Med 2002; 8: 785-787
10. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998; 52: 235-249
11. Marti HH, Wenger RH, Rivas LA et al. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996; 8: 666-676
12. Marti HH, Gassmann M, Wenger RH et al. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney Int 1997; 51: 416-418
13. Morishita E, Masuda S, Nagao M et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997; 76: 105-116
14. Sakanaka M, Wen TC, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95: 4635-4640
15. Celik M, Gokmen N, Erbayraktar S et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263
16. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is safe and beneficial. Mol Med 2002; 8: 495-505
17. Anagnostou A, Lee ES, Kessimian N et al. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 1990; 87: 5978-5982
18. Carlini RG, Alonzo EJ, Dominguez J et al. Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int 1999; 55: 546-553
19. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 1995; 47: 740-745
20. Ribatti D, Presta M, Vacca A et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 1999; 93: 2627-2636
21. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-228
22. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438
23. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-637
24. Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436
25. Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7
26. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600
27. Bahlmann FH, de Groot K, Duckert T et al. Erythropoietin stimulates endothelial progenitor cell proliferation and differentiation. Kidney Int 2003; 64: in press
28. Llevadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399-405
29. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiological stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346
30. Calvillo L, Latini R, Kajstura J et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003; 100: 4802-4806